Jonathan Bye
Lawyers
Filters
Jazz Pharmaceuticals $1 billion exchangeable senior notes offering
The exchangeable notes are due 2030
CytomX Therapeutics $58.3 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
SGH $175 million convertible notes offering and capped call transactions
The 2% convertible senior notes are due 2030
IDEAYA Biosciences $302.5 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Recursion Pharmaceuticals $230 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Bloom Energy $402.5 million green convertible notes offering
The 3% green convertible senior notes are due 2029
RxSight $115 million follow-on offering
The stock is listed on the Nasdaq Global Market
Nurix Therapeutics $175 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Market
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
IDEAYA Biosciences $350 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market